Outcomes of second-line treatment after fludarabine cyclophosphamide and rituximab in patients with chronic lymphocytic leukemia outside clinical trials
Israeli CLL Study Group
Research output: Contribution to journal › Article › peer-review
4Scopus
citations
Fingerprint
Dive into the research topics of 'Outcomes of second-line treatment after fludarabine cyclophosphamide and rituximab in patients with chronic lymphocytic leukemia outside clinical trials'. Together they form a unique fingerprint.